Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702199 | Practical Radiation Oncology | 2016 | 28 Pages |
Abstract
Dosimetric parameters are strong predictors of symptomatic RP in patients undergoing trimodality therapy for esophageal cancer. Mitigating the risk of RP in these patients should be an important consideration during treatment planning.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Talha MD, Thomas M. MD, Pooja BS, Walter J. MD, Steven J. MD, Joshua E. MD,